Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link Tirzepatide vs. Semaglutide: Key Differences & Benefits Hubmed Retatrutide vs. Tirzepatide Best Weight Loss Peptide? Obesity pharmacotherapy in older adults: a narrative review of evidence International Journal of Obesity Liraglutide vs Tirzepatide for Weight Loss: Expert Insights and Results IVDrips Comparative Efficacy and Safety of Semaglutide, Cagrilintide, and CagriSema in Adults with Overweight or Obesity: A Bayesian Network Meta Analysis Journal of Clinical Question